Michael Tracy

Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia.

J. Griffiths, P. Workman, E. Aboagye, 1997, Cancer research.

The pharmacokinetics, bioavailability and biodistribution in mice of a rationally designed 2-nitroimidazole hypoxia probe SR-4554.

P. Workman, E. Aboagye, K. Ryan, 1996, Anti-cancer drug design.

A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopy

R. Ruddle, M. Campbell, S. Tan, 2009, British Journal of Cancer.